Erwin Reisner completed his PhD at the University of Vienna, focusing his research on 'Redox Activated Ruthenium Anticancer Drugs'. Following his PhD, he worked on different aspects of bio-inspired energy conversion as a postdoc at MIT; he studied synthetic models of the diiron(II) active site of soluble Methane Monooxygenase, which selectively converts natural gas to methanol. Dr. Reisner then joined the Armstrong group at the University of Oxford to work on solar hydrogen production with enzyme-nanoparticle hybrid systems. His independent career started at The University of Manchester in 2009 with an EPSRC fellowship. He was appointed to a tenured faculty position (University Lecturer) at the University of Cambridge (2010). Dr. Reisner received his Habilitation from the University of Vienna (2010), became a fellow and College Lecturer at St. John's College, Cambridge (2011), head of the Christian Doppler laboratory (2012), and co-director of the EPSRC Doctoral Training in Functional and Sustainable Nano (2014). His group works on artificial photosynthesis and the generation of solar fuels by combining chemical biology, synthetic chemistry and materials chemistry.